Feedback / Questions
VET3-TGI - KaliVir
https://www.businesswire.com/news/home/20251119270996/en/KaliVir-Immunotherapeutics-Announces-Clinical-Trial-Collaboration-and-Supply-Agreement-with-Roche-to-Evaluate-VET3-TGI-in-Combination-with-Atezolizumab-Tecentriq-in-Advanced-Solid-Tumors
Nov 19, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next